COSIMPLI Trademark

Trademark Overview

On Monday, January 11, 2016, a trademark application was filed for COSIMPLI with the United States Patent and Trademark Office. The USPTO has given the COSIMPLI trademark a serial number of 86871660. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2019. This trademark is owned by Pfizer Inc.. The COSIMPLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
cosimpli

General Information

Serial Number86871660
Word MarkCOSIMPLI
Filing DateMonday, January 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 2, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
Translation of Words in MarkThe wording "COSOMPLI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 16, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, December 2, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 2, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, April 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2019EXTENSION 5 GRANTED
Monday, April 22, 2019EXTENSION 5 FILED
Thursday, April 25, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 22, 2019TEAS EXTENSION RECEIVED
Saturday, October 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 18, 2018EXTENSION 4 GRANTED
Thursday, October 18, 2018EXTENSION 4 FILED
Thursday, October 18, 2018TEAS EXTENSION RECEIVED
Wednesday, February 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 12, 2018EXTENSION 3 GRANTED
Monday, February 12, 2018EXTENSION 3 FILED
Monday, February 12, 2018TEAS EXTENSION RECEIVED
Saturday, October 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 26, 2017EXTENSION 2 GRANTED
Thursday, October 26, 2017EXTENSION 2 FILED
Thursday, October 26, 2017TEAS EXTENSION RECEIVED
Thursday, March 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 21, 2017EXTENSION 1 GRANTED
Tuesday, March 21, 2017EXTENSION 1 FILED
Tuesday, March 21, 2017TEAS EXTENSION RECEIVED
Tuesday, November 1, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 6, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 1, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 28, 2016ASSIGNED TO LIE
Wednesday, July 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 15, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION WRITTEN
Tuesday, April 26, 2016ASSIGNED TO EXAMINER
Friday, January 22, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, January 22, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, January 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 14, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

cosimpli preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases